Sichenzia Ross Ference represented Relmada Therapeutics in the transaction.Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a late-stage biotechnology company, executed a $100 million At-The-Market offering facility (“ATM”). Jefferies…
Relmada Therapeutics’ $100 Million At-The-Market Offering
